FAQs

Inato is a global clinical trial platform that unlocks patient access through a unique combination of AI and site engagement. Our proprietary AI-driven platform optimizes every step of the clinical trial journey:

1. Study Design: Gain real-world protocol insights from sites across the globe and confirm interest at scale
2. Site Selection: Leverage existing data and rich profiles across sites to understand patient access and inform final site and patient allocations
3. Patient Enrollment: Automate patient identification & chart review with AI to reduce burden and engage with patients at scale.

With Inato, sponsors can select more motivated and experienced sites, accelerate activation and enrollment, increase patient representation, and gain a competitive edge—all while integrating seamlessly into their existing trial structure, whether working with CROs, fully outsourced, hybrid, or in-house models.

Yes! We have active sites in 50+ countries primarily in North America, Europe, and Central and South America.

Right now, 5,000+ sites have profiles on our platform in 50+ countries primarily in North America, Europe, and Central and South America. Mainly focusing in the below therapeutic areas:

• • Pulmonology

  • Oncology

  • Infectious Disease & Vaccine

  • Neurology

  • Metabolism & Endocrinology

  • Dermatology

  • Cardiology

  • Rheumatology

  • Psychiatry & Psychology

  • Allergy & Immunology

  • Urology & Women’s Health

  • Gastroenterology

Our platform is not a site network or a site list. We actively engage and enable research sites, helping them showcase their capabilities and match with the right trials. Through AI-driven insights and hands-on support, we empower sites to take control of their participation while giving sponsors access to a more diverse and committed network. By prioritizing collaboration over one-sided selection, Inato makes clinical trials more inclusive, efficient, and successful for everyone involved.

Our goal is to launch within three weeks of our strategy call, though we aim for an even faster timeline. The speed is ultimately influenced by the sponsor’s feedback timeline and the number of stakeholders involved in the review process. We’re fully prepared to adapt to your pace to get your trial up and running as efficiently as possible.

• Tips to accelerate your trial launch:

  • Early alignment on key agreements: CDA process alignment and  signatures

  • Timely communication and responsiveness: Clear and prompt responses to emails and action items help maintain momentum and prevent unnecessary delays

  • Providing study details early: Sharing critical study details in advance as per request of the Inato team ensures a smoother onboarding process

We cover over 70 disease areas. This extensive reach allows sponsors to find suitable sites for various clinical trials. Some of our areas are listed below:

• • Pulmonology

  • Oncology

  • Infectious Disease & Vaccine

  • Neurology

  • Metabolism & Endocrinology

  • Dermatology

  • Cardiology

  • Rheumatology

  • Psychiatry & Psychology

  • Allergy & Immunology

  • Urology & Women’s Health

  • Gastroenterology

Traditional site selection often focuses on a limited pool of large academic centers, with the top 5% of research sites conducting about 70% of trials. Inato expands this reach by offering a platform that connects sponsors with untapped community-based sites worldwide, enabling access to diverse patient populations and enhancing trial inclusivity.

Inato flipped the model by empowering research sites to proactively select trials that align with their interests and patient demographics. Our AI-enhanced technology streamlines processes like enrollment planning and patient pre-screening.

Our technology has significantly reduced site pre-screening times by more than 50%, and up to 90% in some cases, accelerating patient identification and enrollment. This collaborative approach leads to higher engagement levels.

Learn more about Patient Pre-Screening.

Inato has expanded access to clinical trials by adding over 5,000 community-based research sites across more than 50 countries, covering over 70 disease areas, thereby enhancing diversity in clinical research. By partnering with community-based sites, Inato brings clinical trials to patients in their local settings, facilitating participation from underrepresented groups.

These community-based sites have deep, existing connections with the people they serve and have the established trust necessary to recruit and retain underserved populations. Our sites also typically have staff and language capabilities that reflect their communities. 94% of Inato's diverse sites have at least one non-English speaker or one diverse staff member.

Sponsors can track their site selection progress directly within our platform. For performance monitoring, we provide regular updates within the platform and review key metrics during live check-in calls to ensure transparency and alignment on trial goals.

Our pricing model is designed to be flexible based on your specific needs. We partner with sponsors on everything from individual trials to portfolio-wide studies across multiple therapeutic areas and geographies. Our approach is primarily performance-based where every site commits to an enrollment goal, and costs are aligned with successful delivery. This is combined with tech access to ensure seamless execution and optimal results.

For sites, Inato is completely free, allowing more motivated and diverse sites to participate without financial barriers. This gives sponsors access to a broader, more engaged site network, leading to faster activation, improved enrollment, and increased patient representation.

At Inato, we prioritize data security and regulatory compliance at every level. We are fully HIPAA compliant, ensuring that all personal health information (PHI) is protected in accordance with the highest industry standards. Our team is extensively trained in HIPAA regulations, and we integrate compliance into our daily operations through secure data encryption, strict access controls, and rigorous security protocols. 

In addition, we are ISO 27001 certified, adhering to the internationally recognized standard for information security management. This certification demonstrates our commitment to safeguarding sensitive data and continuously improving our security practices.

Learn more about our security practices.